General Information of This Metabolic Reaction (MR) (ID:
MR002552) |
Formula |
Reactant |
Brivaracetam |
Product |
Brivaracetam metabolite M1b |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Hydroxylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects. Drug Metab Dispos. 2008 Jan;36(1):36-45.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.